Status:
RECRUITING
Fecal Microbiota Transplantation for Ulcerative Colitis
Lead Sponsor:
Guangzhou First People's Hospital
Conditions:
Ulcerative Colitis
Fecal Microbiota Transplantation
Eligibility:
All Genders
18-65 years
Phase:
PHASE2
PHASE3
Brief Summary
Fecal microbiota transplantation (FMT) is a strategy that infuses a fecal suspension containing a healthy donor's microbiota into a patient's gut to restore his/her intestinal microbiome. Fecal microb...
Detailed Description
The present clinical trial aims to re-establish a gut functionality state of intestinal flora through FMT as a therapy for ulcerative colitis(UC). We established a standard microbiota isolation from d...
Eligibility Criteria
Inclusion
- Active, moderate to severe severity (Mayo score more than 6)
- Safety using history of 5-ASA
- Able to undergo endoscopy examination
Exclusion
- Antibiotic using in 7 days
- High risk of toxic megacolon
- Colon cancer or neoplasia in pathophysiology
- Other severe diseases (eg: cardiovascular, respiratory, gastroenteral and kidney diseases)
Key Trial Info
Start Date :
January 20 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2030
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT03804931
Start Date
January 20 2019
End Date
December 31 2030
Last Update
January 15 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Guangzhou First People's Hospital
Guangzhou, Guangdong, China